Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | CFTR | P13569 | 2/20 | 0.38 |
| ▸ | GOPC | Q9HD26 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL731336 | 0.86 | NPC1 (0.50) | NPC1RAB9AALDH1A1LMNAMAPT | |
| SCHEMBL8178876 | 0.79 | CHRNB4 (0.42) | NPC1RAB9A | |
| SCHEMBL5001783 | 0.79 | CHRNB4 (0.42) | ALDH1A1MAPTHTTHPGD | |
| SCHEMBL678399 | 0.79 | CYP11B2 (0.51) | ALDH1A1 | |
| SCHEMBL678820 | 0.79 | HSD17B1 (0.44) | — | |
| SCHEMBL5793895 | 0.78 | PTGS2 (0.42) | NPC1RAB9APOLBALDH1A1MAPT | |
| SCHEMBL11279823 | 0.78 | MAPK14 (0.41) | NPC1RAB9AALDH1A1LMNAMAPT | |
| SCHEMBL3519376 | 0.78 | MAPK14 (0.41) | ALDH1A1MAPT | |
| SCHEMBL28756264 | 0.78 | MT-CO2 (0.53) | ALDH1A1MAPT | |
| SCHEMBL5225774 | 0.78 | HTR2C (0.37) | NPC1RAB9AALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116354829-A | Preparation method and application of pentyenediamine adipate | 中国科学院长春应用化学研究所 | 2023-06-30 | — | — | CN | claimed |
| CN-111217710-B | Method for preparing 1, 5-pentanediamine by organic catalysis of L-lysine chemical decarboxylation | 中国科学院长春应用化学研究所 | 2021-06-15 | — | — | CN | claimed |
| CN-111217710-A | Method for preparing 1, 5-pentanediamine by organic catalysis of L-lysine chemical decarboxylation | 中国科学院长春应用化学研究所 | 2020-06-02 | — | — | CN | claimed |
| US-4255292-A | Perfuming composition containing 3-phenyl-cyclohex-2-en-1-one | FIRMENICH SA (CH) | 1981-03-10 | — | — | US | claimed |
| US-12509418-B2 | Chromophoric compounds and UV-absorbing compositions | LYGG CORPORATION (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4642424-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | LYGG Corporation (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025206106-A1 | METHODS FOR PRODUCING 3-PHENYLCYCLOHEXENONE COMPOUND AND DERIVATIVE THEREOF | 住友化学株式会社 | 2025-10-02 | — | — | WO | disclosed |
| WO-2025206106-A1 | METHODS FOR PRODUCING 3-PHENYLCYCLOHEXENONE COMPOUND AND DERIVATIVE THEREOF | 住友化学株式会社 | 2025-10-02 | — | — | WO | disclosed |
| US-20250270164-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | LYGG CORPORATION | 2025-08-28 | — | — | US | disclosed |
| CN-116354829-B | Preparation method and application of pentyenediamine adipate | 中国科学院长春应用化学研究所 | 2025-02-07 | — | — | CN | disclosed |
| WO-2024145346-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | LYGG CORPORATION (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240018145-A1 | POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR TREATING OR PREVENTING INFLUENZA | MERCK SHARP & DOHME LLC (US) | 2024-01-18 | — | — | US | disclosed |
| US-5114493-A | Smoking compositions containing a hexahydrobenzofuranone flavorant | PHILIP MORRIS INC. (US) | 1992-05-19 | — | — | US | disclosed |
| US-4255292-A | Perfuming composition containing 3-phenyl-cyclohex-2-en-1-one | FIRMENICH SA (CH) | 1981-03-10 | — | — | US | disclosed |
| US-4255292-A | Perfuming composition containing 3-phenyl-cyclohex-2-en-1-one | FIRMENICH SA (CH) | 1981-03-10 | — | — | US | disclosed |
| US-4255292-A | Perfuming composition containing 3-phenyl-cyclohex-2-en-1-one | FIRMENICH SA (CH) | 1981-03-10 | — | — | US | disclosed |
| US-4127583-A | Preparation of 3-(pyridinyl)-2-cyclohexene-1-ones | STERLING DRUG INC. (US) | 1978-11-28 | — | — | US | disclosed |
| US-4111946-A | Preparation of 3-(pyridinyl)-2-cyclohexen-1-ones | STERLING DRUG INC. (US) | 1978-09-05 | — | — | US | disclosed |
| US-4075217-A | Conversion of 3-(pyridinyl)-2-cyclohexen-1-one to 3-(pyridinyl)anilines | STERLING DRUG INC. (US) | 1978-02-21 | — | — | US | disclosed |
| US-4026900-A | 3-(Pyridinyl)-2-cyclohexen-1-ones | STERLING DRUG INC. (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270164-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | ERCC1, TYR, ERCC5 | NPC1 1517/4885RAB9A 2211/4885POLB 1012/4885 |
| US-12509418-B2 | Chromophoric compounds and UV-absorbing compositions | LBR, ERCC1, MC1R | NPC1 968/4885RAB9A 2940/4885POLB 940/4885 |
| US-20240018145-A1 | POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR TREATING OR PREVENTING INFLUENZA | DNASE1, RNASEH1, RNASE1 | NPC1 902/4885RAB9A 3285/4885POLB 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.